CANTA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Cantargia operates in the pharmaceutical industry and focuses on the development of treatments for cancer and inflammatory diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Cantargia was founded in 2009 and is headquartered in Lund, Sweden.
Læs mereOmsætning mio.
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Delårsrapport Q2'26
Delårsrapport Q3'26
Årsrapport '26
Gå ikke glip af noget - opret en konto og få alle de mulige fordele